glabridin has been researched along with Cancer of Prostate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, W; Liang, L; Sang, X; Wang, F; Zhang, F | 1 |
1 other study(ies) available for glabridin and Cancer of Prostate
| Article | Year |
|---|---|
The toxicity mechanism of glabridin in prostate cancer cells is involved in reactive oxygen species-dependent PI3K/Akt pathway: Integrated utilization of bioinformatic analysis and in vitro test validation.
Topics: Acetylcysteine; Apoptosis; Caspase 3; Cell Proliferation; Computational Biology; Humans; In Vitro Techniques; Male; Phosphatidylinositol 3-Kinases; Prospective Studies; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Reactive Oxygen Species | 2022 |